hairtect.jp

What It Is

Hairtect (hairtect.jp) is not a typical SaaS or enterprise software product. Instead, it is an online AGA consultation and medication delivery service for individual users in Japan. Users can consult, book appointments, and make purchases through the official LINE account, receive a doctor’s consultation at home via smartphone or PC, and then have treatment medication delivered by the service provider.

Core Features and Service Flow

Based on the collected content, the core modules include free LINE consultations, 30-second appointment booking, online doctor consultations, AGA medication prescriptions, and home delivery. The medications include finasteride, oral minoxidil tablets, and topical minoxidil lotion, with multiple before-and-after treatment cases shown. The page also emphasizes that “all medication ingredients have been tested,” that cumulative prescriptions have exceeded 50 million tablets, and that 90% of users who took the medication for 180 days or longer felt they maintained or increased their hair volume. However, these are all medical service capabilities, not enterprise software capabilities such as collaboration, approvals, CRM, or data platforms.

Pricing

Its pricing information is relatively transparent: bulk purchase of finasteride alone averages 2,200 yen per month; finasteride + minoxidil 2.5 mg averages 3,080 yen per month; and finasteride + minoxidil 5 mg averages 3,850 yen per month. One case also mentions finasteride + minoxidil tablets + 7% topical solution at an average of 9,130 yen per month. For shipping, subscription delivery costs 500 yen, while one-time/bulk delivery costs 1,200 yen. The page states that LINE consultations are free, but no free trial or enterprise subscription version was found.

Pros and Cons

The advantages are its extremely simple entry point: consultations, appointments, and purchases are handled through LINE, making it suitable for users who do not want to visit a clinic in person. The pricing tiers are clear, and the lower-cost combinations are appealing. The page also provides case examples, side effect explanations, and usage instructions, offering fairly comprehensive information disclosure. The drawbacks are also clear: the article does not provide details on payment methods, refund/cancellation policies, or customer support SLAs. Some medications are noted as not approved in Japan and are imported for use by individual doctors, so users need to fully understand the medical risks. There is also no information at all on SaaS buyer concerns such as permission management, APIs, third-party system integrations, self-hosting, or audit logs.

Who It’s For and Access from China

It is suitable for individual users living in Japan who want to continue AGA treatment online. It is not suitable as an enterprise software procurement target. Access from mainland China cannot be determined from the text and is marked as unknown.